Company Monitoring Page for Merck

latest headlines for company on cafepharma

Merck’s COVID-19 treatment falls short in prevention study
BioPharma Dive
Tue, 02/21/23 - 04:53 pm
Tags:
Merck, COVID-19, Lagevrio, clinical trials
BioNTech touts differences with Moderna in race for cancer vaccines
Endpoints
Tue, 02/21/23 - 04:41 pm
Tags:
BioNTech, Moderna Therapeutics, Merck, vaccines, cancer, cancer vaccines
Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’
BioPharma Dive
Tue, 02/21/23 - 11:05 am
Tags:
Big Pharma, patents, patent cliff, biosimilars, AbbVie, Humira, Merck, Keytruda, Bristol Myers Squibb, Opdivo
As HQ move nears completion, Merck finds a buyer for its sprawling Kenilworth campus
Fierce Pharma
Mon, 02/20/23 - 12:47 pm
Tags:
Merck, New Jersey, headquarters
Merck seeks more approvals for infectious disease drug
Endpoints
Fri, 02/17/23 - 11:26 am
Tags:
Merck, CMV, FDA, Prevymis
Merck targets BMS' stomach cancer head start with Keytruda win, but past failure casts shadow
Fierce Pharma
Thu, 02/16/23 - 04:54 pm
Tags:
Merck, Keytruda, clinical trials, stomach cancer
Seagen mum on Merck buyout rumors as it bats for blockbuster with Adcetris
BioSpace
Thu, 02/16/23 - 11:27 am
Tags:
Seagen, earnings, Merck, M&A, Adcetris
After several flops, Merck exec stands by aggressive Keytruda prostate cancer program
Fierce Biotech
Thu, 02/16/23 - 11:06 am
Tags:
Merck, Keytruda, prostate cancer
Merck, Glenmark headed to trial after judge scraps early dismissal bid in Zetia antitrust case
Fierce Pharma
Wed, 02/15/23 - 10:52 am
Tags:
Merck, Glenmark, patents, pay-for-delay, legal, Zetia
Merck and Nectin to Study Novel Anti-PVR Candidate with Keytruda
BioSpace
Tue, 02/7/23 - 12:15 pm
Tags:
Merck, Nectin Therapeutics, NTX1088, solid tumors
Led by Merck, Vertex and Lilly, pharma's share prices largely climbed in '22 despite economic angst
Fierce Pharma
Tue, 02/7/23 - 12:00 pm
Tags:
Merck, Vertex Pharmaceuticals, Eli Lilly, pharma stocks
Merck Eyes Third Endometrial Cancer Nod for Keytruda
BioSpace
Fri, 02/3/23 - 10:30 am
Tags:
Merck, Keyruda, clinical trials, endometrial cancer
Merck pill linked to new mutations, study says
Fierce Pharma
Thu, 02/2/23 - 11:15 pm
Tags:
Merck, antivirals, COVID-19, Lagevrio
Q4 earnings roundup: Merck, Lilly, Takeda and BMS release financials
Medical Marketing and Media
Thu, 02/2/23 - 10:55 am
Tags:
earnings, Merck, Takeda, Bristol Myers Squibb, Eli Lilly
The end of the Humira era
EP Vantage
Mon, 01/30/23 - 10:46 am
Tags:
AbbVie, Humira, patents, biosimilars, Merck, Keytruda
Lilly enters ripe BTK field with quick FDA nod in mantle cell lymphoma
Endpoints
Sun, 01/29/23 - 02:14 pm
Tags:
Eli Lilly, Btk inhibitors, FDA, Merck, mantle cell lymphoma, Jaypirca
Will This Billion-Dollar Acquisition Be a Smart Move for Merck?
Motley Fool
Fri, 01/27/23 - 10:47 am
Tags:
Merck, M&A, Imago BioSciences
Construction on Merck's London research hub set to begin in April 2023
Endpoints
Wed, 01/25/23 - 10:40 pm
Tags:
Merck, London, R&D, UK
A Hit and a Miss for Merck’s Keytruda
BioSpace
Wed, 01/25/23 - 10:42 am
Tags:
Merck, Keytruda, prostate cancer, biliary tract cancer
Immuno-oncology goes subcutaneous
EP Vantage
Wed, 01/25/23 - 10:18 am
Tags:
immuno-oncology, oncology, subcutaneous drug delivery, Keytruda, Merck, Tecentriq, Roche

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.